Abstract WP167: Clinical Characteristics and Outcomes of Mixed Cerebral Small Vessel Disease According to the CLAS-ICH Classification

Atsushi Ogawa,Kaori Miwa,Masayuki Shiozawa,Ryoko Inutsuka,Ryo Usui,Yoshito Arakaki,Naruhiko Kamogawa,Sohei Yoshimura,Kazunori Toyoda,Masafumi Ihara,Masatoshi Koga
DOI: https://doi.org/10.1161/str.55.suppl_1.wp167
IF: 10.17
2024-02-01
Stroke
Abstract:Objectives: Mixed location intracerebral hemorrhages/ microbleeds (CMBs) (mixed ICH) is referred to as potential hypertensive arteriolosclerosis/cerebral amyloid angiopathy (CAA) combination, reflecting small vessel disease (SVD) burden. We assess the clinical features in patients with mixed ICH. Methods: We utilized data from a prospective registry, which consecutively enrolled patients diagnosed with acute ICH between January 2011 and December 2021. Patients with ICH were classified into subtypes according to the CLAS-ICH classification: hypertensive arteriolosclerosis ([HTN]-ICH), CAA-ICH, mixed ICH, genetic SVD, and secondary causes. The clinical data of patients with mixed ICH were compared to those with HTN-ICH or CAA-ICH. The outcome measure was unfavorable functional outcomes defined as mRS score of 5-6 at 90-day. Results: Of 2127 patients with ICH (mean age 70±13 years, 57% male), 1374 (65%) had HTN-ICH, 141 (6%) had CAA-ICH, 409 (19%) had mixed ICH, none (0%) had genetic SVD, 203 (10%) had secondary causes. Patients with mixed ICH were older (75±11 vs. 69±13 years) and had a high frequency of CMBs (68% vs. 25%), had lower initial SBP (176±32 vs. 184±30 mmHg) and initial NIHSS (12 [4-21] vs. 14 [7-23]) and more hematoma volume (17 [6–52] vs. 11 [4–24] ml), compared to those with HTN-ICH (all P<0.001). There were no significant differences in hypertension, dyslipidemia, and diabetes. When comparing patients with mixed ICH to those with CAA-ICH, they were younger (75±11 vs. 78±8 years) and had a high frequency of male (54% vs 33%), hypertension (95% vs. 36%) and diabetes (14% vs. 5%) and had higher initial SBP (176 ± 32 vs. 160 ± 29 mmHg) and less hematoma volume (17 [6–52] vs. 44 [18–84] ml)(all P 0.1), while the outcomes for mixed ICH were lower than those for CAA-ICH (32% vs. 44%, p=0.004). In multivariate analysis adjusting for covariates, there was no significant difference in unfavorable outcomes between mixed SVD-ICH and CAA-ICH (odds ratio 1.19 [95% CI, 0.66–2.13]). Conclusions: Mixed ICH harbors similar features of hypertensive SVD rather than CAA. The rates of disability and mortality were comparable across the groups.
peripheral vascular disease,clinical neurology
What problem does this paper attempt to address?